Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AVLNAvalyn Pharma Inc.

Nasdaq · CIK 0001540171
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts164

Identity from submissions API

NameAvalyn Pharma Inc.
CIK0001540171
TickersAVLN
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN452463191
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(206) 707-0340
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Genoa Pharmaceuticals, Inc. (2012-11-16T00:00:00.000Z → 2017-05-24T00:00:00.000Z)
Business address
105 W FIRST ST.
BOSTON
MA
02127
MA
Mailing address
105 W FIRST ST.
BOSTON
MA
02127
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

74 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468718 12952
2026-11-19 4 4 0001193125-26-468543 20264
2026-11-19 4 4 0001193125-26-468542 12958
2026-11-19 4 4 0001193125-26-468541 12962
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011259 001-43251 261566848 33 5017
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011258 001-43251 261566846 33 5099
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011241 001-43251 261566681 33 4786
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011227 001-43251 261566540 33 4765
2026-11-12 4 4 0001193125-26-457571 12442
2026-11-12 10-Q 10-Q 0001193125-26-457071 001-43251 261543534 34 11728616 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-457053 001-43251 261543476 34 309550 1 1
2026-09-17 4 4 0001193125-26-394342 5415
2026-09-17 3 3 0001193125-26-394320 15216
2026-09-16 8-K 8-K 5.02 0001193125-26-393081 001-43251 261383876 34 160488 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001388325-26-000044 005-95651 261283490 34 6853
2026-08-12 10-Q 10-Q 0001193125-26-345820 001-43251 261265409 34 11059039 1 1
2026-08-12 8-K 8-K 2.02,9.01 0001193125-26-345807 001-43251 261265396 34 295571 1 1
2026-08-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002149521-26-000002 005-95651 261264259 34 18347
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002206 005-95651 261247446 34 12061
2026-07-01 8-K 8-K 1.01,9.01 0001193125-26-292834 001-43251 261146557 34 227170 1 1
2026-06-17 8-K 8-K 7.01 0001193125-26-273405 001-43251 261096637 34 183584 1 1
2026-06-03 10-Q 10-Q 0001193125-26-254623 001-43251 261058956 34 9922455 1 1
2026-06-03 8-K 8-K 2.02,9.01 0001193125-26-254581 001-43251 261058922 34 274261 1 1
2026-05-08 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000899140-26-000428 005-95651 26960310 34 108995
2026-05-08 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001072613-26-000386 005-95651 26959155 34 149694
2026-05-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-212017 005-95651 26953597 34 23312
2026-05-05 4 xslF345X06/form4-05052026_040501.xml 0001388325-26-000021 17708
2026-05-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-000743 005-95651 26941034 34 11541
2026-05-05 4 4 0001193125-26-205201 23782
2026-05-04 4 4 0001193125-26-202381 5499
2026-05-01 4 4 0001193125-26-201894 13991
2026-05-01 4 4 0001193125-26-201887 25245
2026-05-01 4 4 0001193125-26-201875 5436
2026-05-01 4 4 0001193125-26-201870 5429
2026-05-01 4 4 0001193125-26-201868 5511
2026-05-01 4 4 0001193125-26-201867 5491
2026-05-01 4 4 0001193125-26-201865 5462
2026-05-01 4 4 0001193125-26-201863 9442
2026-05-01 4 4 0001193125-26-201861 5509
2026-05-01 4 4 0001193125-26-201860 5465
2026-05-01 4 4 0001193125-26-201856 5526
2026-05-01 8-K 8-K 5.03,9.01 0001193125-26-201434 001-43251 26932576 34 489864 1 1
2026-04-30 S-8 S-8 0001193125-26-197739 333-295462 26926819 33 411337 1 1
2026-04-30 424B4 424B4 0001193125-26-197686 333-294932 26926681 33 28368491
2026-04-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001383 333-294932 26919642 33 1791
2026-04-29 3 3 0001193125-26-193328 6029
2026-04-29 3 xslF345X06/form3-04302026_120434.xml 0001388325-26-000017 9685
2026-04-29 3 3 0001193125-26-193145 11167
2026-04-29 3 3 0001193125-26-192926 155073
2026-04-29 3 3 0001193125-26-192838 20599
2026-04-29 3 3 0001193125-26-192819 15778
2026-04-29 3 3 0001193125-26-192803 15751
2026-04-29 3 3 0001193125-26-192773 14405
2026-04-29 3 3 0001193125-26-192759 16891
2026-04-29 3 3 0001193125-26-192729 15160
2026-04-29 3 3 0001193125-26-192688 17691
2026-04-29 3 3 0001193125-26-192686 15782
2026-04-29 3 3 0001193125-26-192678 17133
2026-04-29 3 3 0001193125-26-192661 19178
2026-04-29 3 3 0001193125-26-192655 14063
2026-04-29 CERT AVLN_8A_Cert_1540171.pdf 0001354457-26-000385 001-43251 26914419 34 181588
2026-04-29 S-1/A S-1/A 0001193125-26-189477 333-294932 26910998 33 28900446 1 1
2026-04-27 8-A12B 8-A12B 0001193125-26-182253 001-43251 26901621 34 31989
2026-04-23 S-1/A S-1/A 0001193125-26-173632 333-294932 26888453 33 31147067 1 1
2026-04-08 S-1 S-1 0001193125-26-147573 333-294932 26848084 33 34954783 1 1
2026-03-18 DRS/A filename1.htm 0001193125-26-113967 377-09014 26769059 33 30810285
2026-02-06 DRS filename1.htm 0001193125-26-040979 377-09014 26606981 33 30208572
2023-10-10 D xslFormDX01/primary_doc.xml 06b 0001540171-23-000001 021-494182 231317067 33 11239
2020-05-08 D xslFormDX01/primary_doc.xml 06b 0001540171-20-000002 021-366535 20857997 33 11701
2017-05-24 D/A xslFormDX01/primary_doc.xml 06b 0001140361-17-022149 021-283266 17867147 33 10515
2017-03-24 D xslFormDX01/primary_doc.xml 06b 0001140361-17-013115 021-283266 17711337 33 10482
2015-08-12 D/A xslFormDX01/primary_doc.xml 06b 0001140361-15-031315 021-187115 151046810 33 7997
2015-03-24 D/A xslFormDX01/primary_doc.xml 06b 0001140361-15-013063 021-187115 15722185 33 8001
2012-11-16 D xslFormDX01/primary_doc.xml 06 0001540171-12-000003 021-187115 121211016 33 8631

Latest XBRL company facts

One latest value per concept from companyfacts (164 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 44.52M 2026-11-10 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
ffd NetFeeAmt NetFeeAmt USD 14,274.72 2026-04-28 S-8 2026-04-30 0001193125-26-197739
ffd TtlFeeAmt TtlFeeAmt USD 14,274.72 2026-04-28 S-8 2026-04-30 0001193125-26-197739
ffd TtlOfferingAmt TtlOfferingAmt USD 103.37M 2026-04-28 S-8 2026-04-30 0001193125-26-197739
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-28 S-8 2026-04-30 0001193125-26-197739
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 33,732.31 2026-04-29 S-1/A 2026-04-29 0001193125-26-189477
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 9.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 868,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 321,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -994,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 722.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 638,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.10M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4.23M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 184,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 38,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 38,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AreaOfLand Area of Land sqft 8,774 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap Assets Assets USD 399.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AssetsCurrent Assets, Current USD 333.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap AssetsNoncurrent Assets, Noncurrent USD 65.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 145.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 145.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations USD 93.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 9.81 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 22,500 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 700.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 44.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 44.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap CommonStockValue Common Stock, Value, Issued USD 67,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -86.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap DebtInstrumentUnamortizedDiscountPremiumNet Debt Instrument, Unamortized Discount (Premium), Net USD 183,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap Depreciation Depreciation USD 277,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 34.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ImpairmentLossesRelatedToRealEstatePartnerships Impairment Losses Related to Real Estate Partnerships USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -472,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -386,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 324,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 878,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap InterestExpenseBorrowings Interest Expense, Borrowings USD 647,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 647,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap InterestExpenseOther Interest Expense, Other USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap InterestIncomeOperating Interest Income, Operating USD 7.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap InterestIncomeOther Interest Income, Other USD 6.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 240,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 85,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 986,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 213,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap Liabilities Liabilities USD 29.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 399.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LiabilitiesCurrent Liabilities, Current USD 12.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LineOfCredit Long-term Line of Credit USD 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LongTermDebt Long-term Debt USD 14.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 6.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 6.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 14.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap MarketableSecurities Marketable Securities USD 277.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 182.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 59.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 330.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -155.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -82.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -85.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -85.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -85.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingExpenses Operating Expenses USD 92.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -92.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingLeaseCost Operating Lease, Cost USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingLeaseLeaseIncomeLeasePayments Operating Lease, Lease Income, Lease Payments USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 840,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -899,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD -229,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-345820
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 374,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -96,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 208,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 4.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 241.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 659,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 1 2026-03-31 2026 Q1 10-Q 2026-06-03 0001193125-26-254623
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 372.65M 2026-03-31 2026 Q1 10-Q 2026-06-03 0001193125-26-254623
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 372.22M 2026-03-31 2026 Q1 10-Q 2026-06-03 0001193125-26-254623
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PrepaidInsurance Prepaid Insurance USD 80,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PrepaidInterest Prepaid Interest USD 1.55M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 50.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-06-03 0001193125-26-254623
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 15.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities Proceeds from Sale and Maturity of Held-to-maturity Securities USD 59.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 26.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 15.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-345820
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -85.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 73.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -350.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 831,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 45.99 2026-03-31 2026 Q1 10-Q 2026-06-03 0001193125-26-254623
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.796 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.697 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.045 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.045 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 62.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 160,794 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 12.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 124.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 10.2 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 4.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 10.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 17.32 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 370.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 90,806 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 25.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 25.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071
us-gaap WorkersCompensationLiabilityCurrentAndNoncurrent Workers' Compensation Liability USD 4.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-457071

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →